Quantum Cyber (QUCY) EBT Margin (2022 - 2023)
Quantum Cyber (QUCY) posted EBT Margin of 2413.53% for Q4 2023, up 30.4% sequentially from 3467.71% in Q3 2023, and up 182313.0% YoY from N/an in Q4 2022.
Quantum Cyber (QUCY) EBT Margin (2022 - 2023) Analysis & Trends
Quantum Cyber has reported EBT Margin for 2 years, with the latest figure at 2413.53% in Q4 2023.
- Quarterly EBT Margin rose 182313.0% year-over-year to 2413.53% in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 2936.5% (up 204340.0% YoY) and the FY2025 annual result came in at 3018.31%, down 60231.0% from the prior year.
- EBT Margin grew to 2413.53% in Q4 2023 per QUCY's latest filing, from 3467.71% in the prior quarter.
- Over five years, EBT Margin peaked at 2413.53% in Q4 2023 and troughed at 5781.76% in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 16.04% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.21% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.29% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 22.23% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 6.89% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -12.17% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 22.43% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 28.17% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 13.54% |
| 10 | Quantum Cyber | 16.67 Mn | 11.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -2,413.53% |
| Sep 30, 2023 | -3,467.71% |
| Jun 30, 2023 | -3,314.68% |
| Mar 31, 2023 | -2,623.28% |
| Dec 31, 2022 | -4,236.66% |
| Sep 30, 2022 | -5,781.76% |
| Jun 30, 2022 | -4,983.27% |
| Mar 31, 2022 | -5,631.92% |